Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. on November 10, 2016. The filing serves to announce the company's financial results for the fiscal quarter ended September 30, 2016. The detailed results are contained in a press release furnished as Exhibit 99.1, which is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The provided text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being located in the attached press release (Exhibit 99.1), the content of which is not included in the source text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that results for the quarter ended September 30, 2016, have been announced.
Guidance, Outlook, and Risks
The report includes standard forward-looking statements regarding the company's intentions, beliefs, expectations, and strategies. Management notes that these statements are based on current assumptions and are not guarantees of future performance. Actual results may differ materially due to risks and uncertainties discussed in the company's Annual Report on Form 10-K and other SEC filings. The company does not undertake an obligation to update these statements except as required by law.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the press release (Exhibit 99.1) referenced in this filing.
- Review the company's Form 10-K for a detailed discussion of risk factors affecting future performance.
- Confirm the status of the company's cash position and liquidity as of September 30, 2016, via the full financial statements.
- Note that the registrant name in the filing header is Oculus Innovative Sciences, Inc., despite the request metadata mentioning Sonoma Pharmaceuticals, Inc.